CloudMD’s “Strategic Plan” Starts With $41.4 Million In Revenue, $5.6 Million Net Loss For Q1 2022
In the wake of the consecutive resignations of its CEO and CFO, CloudMD Software & Services Inc. (TSXV: DOC) maintains
Read moreIn the wake of the consecutive resignations of its CEO and CFO, CloudMD Software & Services Inc. (TSXV: DOC) maintains
Read moreOn May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results. The company reported revenues of
Read moreThe rollout of Cognetivity Neurosciences’ (CSE: CGN) flagship product, the CognICA cognitive assessment tool, continues. The firm this morning announced
Read moreNever wanting to put a good cash-producing opportunity to waste, Well Health (TSX: WELL) this morning announced it intends to
Read moreWELL Health Technologies Corp. (TSX: WELL) reported today its financial performance for Q1 2022. The results highlighted a quarterly revenue
Read moreBausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) started trading its securities today.
Read moreCognetivity Neuroscience (CSE: CGN) is looking to expand the scope of its cognitive testing platform. The company this morning announced
Read moreOn Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for the period ended December 31,
Read moreCloudMD Software & Services Inc. (TSXV: DOC) released on Monday its Q4 and full-year 2021 financial results which saw the
Read moreTeladoc Health (NYSE: TDOC) released its Q1 2022 financial results on Wednesday post-closing bell. The timing hinted at unfavorable numbers but
Read more